Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Income from Continuing Operations: 2023-2024

Historic Income from Continuing Operations for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$65.6 million.

  • Upstream Bio's Income from Continuing Operations fell 110.95% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.2 million, marking a year-over-year decrease of 113.52%. This contributed to the annual value of -$65.6 million for FY2024, which is 82.59% down from last year.
  • According to the latest figures from FY2024, Upstream Bio's Income from Continuing Operations is -$65.6 million, which was down 82.59% from -$35.9 million recorded in FY2023.
  • Over the past 5 years, Upstream Bio's Income from Continuing Operations peaked at -$35.9 million during FY2023, and registered a low of -$65.6 million during FY2024.
  • Moreover, its 2-year median value for Income from Continuing Operations was -$50.8 million (2023), whereas its average is -$50.8 million.
  • Data for Upstream Bio's Income from Continuing Operations shows a maximum YoY slumped of 82.59% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Income from Continuing Operations (Yearly) stood at -$35.9 million in 2023, then tumbled by 82.59% to -$65.6 million in 2024.